title: Psychotropics in different causes of itch: systematic review with controlled studies.
abstract: Among the wide range of symptoms neglected or resistant to conventional treatments in clinical practice, itch is emerging gradually as a theme to be studied. Itch complaints and the negative effects in the quality of life are observed in several medical fields. Although the partially obscure pathophysiology, some researchers decided to check and test the use of psychotropic drugs in resistant itch to conventional topical treatments and antihistamines. The objective of this study was to evaluate scientific evidence in psychotropic use in the treatment of itch of various causes. This is a systematic review of scientific literature. The following databases were used: PubMed, Web of Science, Scopus and Scielo. Randomized controlled trials that should focus on treatment with psychotropic drugs of pruritus of various causes were the inclusion criteria. All articles were analyzed by the authors, and the consensus was reached in cases of disagreement. Fifteen articles were included after analysis and selection in databases, with the majority of clinical trials focusing on psychopharmacological treatment of itch on account of chronic kidney disease. Clinical trials with psychotropic drugs mostly indicated significant improvement in the itching. In most trials of chronic kidney disease as basal disease for itch, greater effectiveness was observed with the use of psychotropic drugs compared with placebo or other antipruritic. However, the small amount of controlled trials conducted precludes the generalization that psychiatric drugs are effective for itch of various causes.
authors.affiliation: Universidade Federal do Rio Grande do Norte (UFRN) - Natal (RN), Brazil.
authors.forename: Lízie Emanuelle Eulalio
authors.initials: LE
authors.lastname: Brasileiro
authors.affiliation: Universidade Federal do Rio Grande do Norte (UFRN) - Natal (RN), Brazil.
authors.forename: Dayanna Patrícia de Carvalho
authors.initials: DP
authors.lastname: Barreto
authors.affiliation: Universidade de São Paulo (USP) - São Paulo (SP), Brazil.
authors.forename: Emerson Arcoverde
authors.initials: EA
authors.lastname: Nunes
mesh_terms: D000588:Amines / Q000627:therapeutic use; D000982:Antipruritics / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004316:Doxepin / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
chemical_list: D000588:Amines; D000982:Antipruritics; D003509:Cyclohexanecarboxylic Acids; D011619:Psychotropic Drugs; D004316:Doxepin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin